Bone Aging & The Camouflage Truth
What resorbs underneath — and why we still work on top.
Somewhere between a slide deck and a sales pitch, the aesthetic world convinced itself that we're "replacing bone." We aren't. We're painting over the crack in the wall with very expensive paint, and the wall is still cracking underneath. That's not a scandal — it's just honest. And once you accept it, you inject better.
This chapter isn't a lecture on osteology. It's a short, adult conversation about what bone actually does as we age, why the surface looks the way it does because of it, and why understanding all of that is not the same as reaching for a needle earlier.
WHAT THE BONE ACTUALLY DOES WITH AGE
Slow, uneven, quietly rearranging the whole facade.
The face doesn't age uniformly. Some bones resorb, some remodel, and a few stubborn ones barely change at all. The mandible loses height and projection. The maxilla loses forward support and rotates back. The orbital rim opens up — mostly at the superomedial and inferolateral edges — and the pyriform aperture around the nose widens. Meanwhile the zygoma and the frontal bone remain relatively loyal.
The consequence isn't dramatic in any single week. It's cumulative. Over years the scaffolding shrinks and tilts, and every layer sitting on top of it — periosteum, fat, muscle, SMAS, skin — has less to hold on to. That's the real reason mid-face descent looks the way it does. It's not that fat "fell." It's that the shelf underneath got smaller.
THE FOUR ZONES OF RESORPTION
Where the bone quietly gives way.
| Zone | What resorbs | What appears on the surface |
|---|---|---|
| Orbit | Superomedial & inferolateral rim recede | Hollow upper lid, tear trough, lateral orbital shadow |
| Mid-face / Maxilla | Loss of maxillary angle & forward projection | Flatter cheek, deeper nasolabial fold, lengthening upper lip |
| Pyriform | Aperture widens, alar base loses support | Nasal tip drops, upper lip lengthens, "aged" smile |
| Mandible | Body height reduces, pre-jowl sulcus deepens, angle blunts | Jowl becomes obvious, chin retrudes, jawline loses line |
None of this is new anatomy. What matters is the pattern: bone loss is regional, not global, and the surface complaints patients bring you — the tear trough, the jowl, the flat cheek — are almost always a downstream story about a bony change further underneath.
READING THE SURFACE CLUES
Because you can't see the skull in the mirror.
You don't need a CBCT to notice bone change. The face tells you. A patient whose lateral canthus sits lower than it did a decade ago is showing you a receding lateral orbital rim. A widening alar base with a dropping tip is a pyriform story. A chin that looks "shorter" in profile with a pre-jowl notch is mandibular. Once you start seeing it, you can't un-see it.
"The wrinkle is rarely the problem. It's the shadow of a problem that lives a few millimetres deeper."
This is why the trained eye assesses in three dimensions: rim, projection, angle. Not lines. Lines are receipts, not causes.
THE CAMOUFLAGE TRUTH
We don't rebuild bone. We rearrange light.
Let's say the quiet part out loud. When an aesthetic practitioner claims they are "replacing bone" with a syringe, they are being generous with the word "replacing." What we are actually doing — even with deep, supraperiosteal boluses — is placing a soft, hydrophilic gel on top of a shrinking scaffold to change how light falls on the face. That is camouflage. Sophisticated, useful, sometimes beautiful camouflage. But camouflage.
And, frankly, that is exactly what most patients need. They don't need their zygoma back. They need their cheekbone to look like it's back. That is a lighting job, not a construction job, and it belongs in the layers where light behaves — mid-to-superficial fat compartments, SMAS-adjacent planes, sometimes intradermally with the right product.
The moment we accept we're painters rather than orthopaedic surgeons, our technique quietly improves. We use less product. We work in the layer the change actually lives in. We stop chasing volume for volume's sake.
WHY WE DON'T INJECT "ON THE BONE"
Because the technology to genuinely rebuild it doesn't exist yet.
The industry loves the phrase "on the bone." It sounds architectural. It sounds definitive. It sounds like we're doing something that lasts. In practice, a supraperiosteal bolus is still a soft gel sitting on periosteum. It doesn't ossify. It doesn't integrate with cortex. It doesn't restore lost bone mineral density. It sits, it hydrates, it slowly leaves.
Biostimulators — CaHA, PLLA, PCL and their cousins — are the closest we have, and they're honest about what they do: they encourage the body to lay down new collagen in soft tissue. They don't build osteoid. There is, at the time of writing, no injectable material licensed to genuinely replace resorbed facial bone. Anyone selling you otherwise is selling you an idea, not a molecule.
And there's a safety point too. The deeper you go, the more expensive the mistakes get. The pyriform, the deep temple, the sub-SMAS mid-face — these are places where confidence and anatomy have to earn each other. Depth is not a virtue on its own.
UNDERSTANDING ≠ INJECTING EARLIER
The most important paragraph in this chapter.
Here is the trap. Once a practitioner learns about bone resorption, the reflex is to start "prehabilitating" — injecting the mid-thirties patient because "the bone is going to go anyway." That's not clinical thinking. That's inventory management.
Understanding bone aging is a diagnostic upgrade, not a treatment trigger. It teaches you why the fold formed, not that you must fill it. It teaches you to place product where the shadow actually lives, not to place more product than the face is asking for. And it teaches you when to say the most under-used sentence in aesthetics: we don't need to do this today.
"Knowing the bone resorbs is not a licence to inject earlier. It's a licence to inject smarter."
CLOSING THOUGHT
Camouflage, done honestly, is a craft.
There is nothing shameful about superficial correction. Painters have been camouflaging shadow with pigment for six centuries and no one accuses them of being frauds. Our job as injectors is to see the bony story, understand it, respect it — and then choose the most economical, most superficial intervention that changes how light falls.
Do that, and the face looks like itself, only rested. Miss it, and you get the familiar over-filled mid-face that fools no one, least of all the patient. Bone aging is real. Our tools are modest. The two truths belong in the same sentence.